Each year, scientists create an influenza (flu) vaccine that protects against a few specific influenza strains that researchers predict are going to be the most common during that year. Now, a new study shows that scientists may be able to create a ‘universal’ vaccine that can provide broad protection against numerous influenza strains, including those that could cause future pandemics.
The study appears in mBio, the online open-access journal of the American Society for Microbiology.
“The reason researchers change the vaccine every year is that they want to specifically match the vaccine to the particular viruses that are circulating, such as H1N1. If the vaccine is just a little bit different to the target virus, it is not expected to offer much protection,” said principal investigator of the study Jeffery Taubenberger, MD, PhD, Chief of Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID). “What we have done is design a strategy where you don’t have to think about matching the vaccine antigen to the virus at all.”
In the new study, researchers at the NIAID used a virus-like particle vaccine cocktail that expressed a handful of different subtypes of a key surface protein of the influenza virus: hemagglutinin H1, H3, H5 and H7. “There are 16 different hemagglutinin subtypes that circulate in birds and are thought to be the basis for current and future influenza pandemics,” said Dr. Taubenberger. “The hypothesis was that the presentation of these different viral proteins would stimulate the development of cross-protective immunity that would provide broader protection against multiple subtypes.”
The researchers picked the H1 and H3 subtypes because they have been the major cause of human seasonal flu outbreaks since 1918. They chose the H5 and H7 subtypes because they have been the cause of recent bird flu outbreaks and have pandemic potential. This selection also provided a broad representation of hemagglutinins across the phylogenetic tree.
In a series of experiments, the researchers found that 95% of mice vaccinated with the investigational cocktail were protected against a lethal challenge with eight different influenza strains expressing seven different influenza A subtypes, compared to only 5% of mice who received mock vaccinations.
“Almost all of the animals that were vaccinated survived, including mice that were challenged with viruses that expressed hemagglutinin subtypes that were not in the vaccine at all, viruses that expressed H2, H6, H10, and H11,” said Dr. Taubenberger. “What that suggests is that this approach really gives us broad spectrum protection, and could serve as a basis for an effective pre-pandemic vaccine.”
Additional experiments showed that the vaccine was durable, effective for at least 6 months, and that it worked well in older mice. This is important given that elderly people are particularly susceptible to severe disease following influenza infection, and current vaccines are less efficacious in the elderly than in younger people.
“These initial findings are very positive and suggest a promising and practical strategy for developing a vaccine with amazing, broad protection,” said Dr. Taubenberger.
Read more: UNIVERSAL FLU VACCINE IN THE WORKS
The Latest on: Universal Flu Vaccine
[google_news title=”” keyword=”Universal Flu Vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Universal Flu Vaccine
- Longhorn Vaccines and Diagnostics Presents New Data on its Best-In-Class Infectious Disease Vaccine and Antibody Portfolio at ECCMID 2024on April 27, 2024 at 1:00 am
LHNVD-105, a universal influenza vaccine, shows strong immunogenicity at low doses in pigs, validating previous studies in rodents Monoclonal antibodies generated by LHNVD-105 demonstrates the need ...
- Bhutan closer to achieving universal immunisation coverage with 99.6 % children vaccinatedon April 26, 2024 at 7:08 am
Bhutan has made significant progress in achieving the Universal Immunisation coverage target. The country has vaccinated 99.6 per cent of children so far. This is according to data released by the ...
- Swine Flu Newson April 24, 2024 at 5:00 pm
Universal Flu Vaccine Protects Against Variants of Both Influenza A and B Viruses, Researchers Find Aug. 25, 2022 — A new universal flu vaccine protects against diverse variants of both ...
- Is There a Vaccine for H5N1 Influenza?on April 22, 2024 at 2:31 pm
On the heels of a multi-state outbreak of highly pathogenic avian influenza A (H5N1) in dairy cows, experts told MedPage Today that a trio of H5N1 vaccines for humans has already been developed and ...
- A Universal Vaccine Against Any Viral Variant? A New Study Suggests It’s Possibleon April 22, 2024 at 1:37 pm
A universal vaccine would train the body to recognize and eradicate new viral strains, even if they've mutated into nearly unrecognizable forms.
- Vaccine Breakthrough Could Mean Future-Proof Shots With No Need For Boosterson April 19, 2024 at 7:46 am
A new vaccine platform could see us waving goodbye to boosters for some diseases, as one shot could cover every possible future strain of a virus. So far, it’s only been tested out in mice, but the ...
- A one-shot vaccine for COVID, flu and future viruses? Researchers say it's comingon April 18, 2024 at 3:43 pm
But what if it were possible to protect against COVID and the flu, and other unknown viruses that haven't yet emerged, with just one shot? If that became reality, seasonal or annual boosters would be ...
- Universal Vaccine Strategy Boosts Body’s RNAi Response to Viruseson April 16, 2024 at 4:54 pm
Researchers say there is little chance of a virus mutating to avoid this vaccination strategy, which blocks viral ability to suppress host RNAi responses.
- Universal vaccine may be effective against any variant of any viruson April 16, 2024 at 4:54 pm
Scientists at the University of California, Riverside (UCR) has recently developed a revolutionary RNA-based strategy for a universal vaccine ...
- Study shows potential for universal flu vaccine with broad antibody responseon April 15, 2024 at 7:52 pm
Study discusses the potential of universal influenza vaccines, emphasizing the importance of antibody breadth and Fc receptor (FcR) effector functions in protecting against various influenza strains, ...
via Bing News